FDA Clearance Tracker · P100018-S043
Pipeline Vantage Embolization Device with Shield Technology
Last checked: Nov 20, 2026Latest source record: Jun 6, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Jun 6, 2024
Approved
Time to decision
237 days
Received Oct 13, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P100018-S043
- Device name
- Pipeline Vantage Embolization Device with Shield Technology
- Applicant location
- Irvine, CA
- Received
- Oct 13, 2023
- Decided
- Jun 6, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P100018
Device type
- Device type
- Intracranial aneurysm flow diverter (OUT)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
approval of the protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P100018/S034
Source documents
Other decisions for Micro Therapeutics, Inc. d/b/a ev3 Neurovascular
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K241388 · Decided Jan 2, 2025 · 232 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
K243418 · Decided Dec 2, 2024 · 28 days after receipt
Device type: Apparatus, Suction, Ward Use, Portable, Ac-Powered (JCX) · General & Plastic Surgery
K243080 · Decided Oct 29, 2024 · 29 days after receipt
Device type: Catheter, Thrombus Retriever (NRY) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.